Concord Medical Services Holdings Ltd financials

  1. Home
  2. Financials
  3. CCM
Concord Medical Services Holdings Ltd reports to SEC EDGAR in CNY (it files a 20-F/40-F as a foreign private issuer), so every monetary figure below is in CNY as filed, not US dollars.
CCM CIK 0001472072

Source: EDGAR filings · Built 2026-06-19T00:38:19Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Free Cash Flow -258.15M -548.52M -389.47M -439.67M -638.29M -397.79M
EBITDA -121.86M -411.03M -344.16M -401.86M -363.86M -245.22M
Working Capital -1.01B -1.14B -1.33B -361.44M -220.05M 163.88M
Net Debt 3.32B 3.69B 3.22B 3.06B 2.56B 2.02B
Gross Margin 5.68% -21.13% -14.71% -33.86% -12.84% 7.69%
Operating Margin -57.56% -142.06% -88.92% -116.65% -103.42% -185.77%
Net Margin -20.43% -82.29% -57.17% -108.78% -61.25% -182.23%
Return on Equity (ROE) 4.41% 13.52% 14.03% 26.27% 19.81% 46.76%
Return on Assets (ROA) -1.42% -4.58% -4.92% -8.15% -4.36% -5.81%
Current Ratio 0.48× 0.46× 0.32× 0.68× 0.73× 1.32×
Debt-to-Equity -1.72× -1.71× -1.54× -1.73× -1.98× -3.55×
Effective Tax Rate -1.62% 2.61% 4.42% 8.44% -1.24% -8.52%
Cash Conversion Ratio 2.17× 1.29× 0.93× 0.44× 1.32× 0.74×
Accruals Ratio 0.02× 0.01× -0.00× -0.05× 0.01× -0.01×
SBC % of Revenue — — 0.00% -1.31% 3.31% 12.12%
CapEx Coverage -3.58× -2.64× -2.45× -0.97× -1.29× -1.37×
Free Cash Flow Per Share ¥-1.97 ¥-4.19 ¥-2.97 ¥-3.35 ¥-4.87 ¥-3.04

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenue from Contract with Customer, Excluding Assessed Tax 64.97M 51.32M 73.33M 65.26M 69.54M 26.07M
Revenues 65.85M 52.60M 75.69M 68.45M 76.21M 34.18M
Cost of Revenue 62.16M 63.45M 86.48M 90.54M 85.14M 32.17M
Gross Profit 3.69M -10.85M -10.79M -22.10M -8.93M 2.00M
Operating Income (Loss) -37.39M -72.91M -65.21M -76.13M -71.92M -48.43M
Income Tax Expense (Benefit) 867.00K -2.40M -3.46M -10.28M -1.03M -5.77M
Net Income (Loss) Attributable to Parent -13.27M -42.23M -41.93M -70.99M -42.59M -47.51M
Earnings Per Share, Basic $-0.10 $-0.32 $-0.32 $-0.54 ¥-6.26 ¥-5.11
Weighted Average Number of Shares Outstanding, Basic 131.05M 131.05M 131.05M 131.05M 131.05M 131.05M
Earnings Per Share, Diluted $-0.10 $-0.32 $-0.32 $-0.54 ¥-6.26 ¥-5.11
Weighted Average Number of Shares Outstanding, Diluted 131.05M 131.05M 131.05M 131.05M 131.05M 131.05M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 42.58M 29.62M 8.19M 22.95M 24.70M 51.23M
Assets, Current 134.69M 134.80M 86.93M 110.16M 91.72M 103.60M
Assets 936.26M 921.51M 852.68M 870.63M 977.62M 817.55M
Liabilities, Current 279.48M 291.17M 274.85M 162.57M 126.25M 78.49M
Long-term Debt, Excluding Current Maturities 352.56M 369.03M 280.85M 358.32M 341.87M 301.62M
Liabilities 671.70M 699.88M 606.62M 578.39M 547.07M 449.61M
Stockholders' Equity Attributable to Parent -300.74M -312.41M -298.87M -270.25M -215.00M -101.60M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities -28.86M -54.49M -38.94M -31.42M -56.39M -35.21M
Payments to Acquire Property, Plant, and Equipment 8.05M 20.66M 15.92M 32.33M 43.78M 25.75M
Net Cash Provided by (Used in) Investing Activities 7.72M -81.30M -6.71M -17.22M -88.81M -81.82M
Net Cash Provided by (Used in) Financing Activities 28.20M 157.00M 36.29M 55.54M 100.81M 174.45M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (CCM CIK 0001472072), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

ARQT

ARCUTIS BIOTHERAPEUTICS, INC.

H

Hyatt Hotels Corp

RBBN

RIBBON COMMUNICATIONS INC.